ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
89
ENDOMETRIOSIS TREATMENT OPTIMIZATION BY INTRODUCING
A SIX-COMPONENT VAGINAL PHYTOCOMPLEX SUPPOSITORY: A
CONSERVATIVE APPROACH
Shahnoza Asqaraliyeva
Andijan State Medical Institute, Uzbekistan
Email: [your_email@example.com]
https://doi.org/10.5281/zenodo.16025079
Abstract
Endometriosis is a chronic gynecological condition that significantly
impacts women of reproductive age, often leading to pelvic pain, menstrual
irregularities, and infertility. Traditional conservative treatments provide
symptomatic relief but are often associated with side effects or limited long-
term efficacy. This research explores the conservative management of
endometriosis through the application of a novel vaginal suppository composed
of six herbal components: Ashwagandha, Nigella sativa (black seed), Propolis,
Artemisia absinthium (wormwood), Cuminum cyminum (zira), and Melissa
officinalis (lemon balm). These components are selected for their well-
documented anti-inflammatory, immunomodulatory, and antioxidant effects.
The study aims to assess the efficacy of this phytocomplex in reducing
inflammation and alleviating clinical symptoms. Preliminary methodology
includes a 14-day course of treatment in ambulatory patients with evaluation
through clinical (VAS scale) and laboratory (CRP, ESR, NLR) parameters. This
phytotherapeutic approach represents an innovative, integrative, and
potentially safer method in the conservative management of endometriosis.
Keywords
Endometriosis, phytotherapy, vaginal suppository, inflammation, CRP,
integrative gynecology
Introduction
Endometriosis is a chronic, estrogen-dependent, inflammatory disease
affecting approximately 10% of women of reproductive age, which equates to
more than 190 million women globally, according to the World Health
Organization (WHO). It is characterized by the presence of endometrial-like
tissue outside the uterine cavity, commonly involving the ovaries, pelvic
peritoneum, and other reproductive structures. This ectopic tissue undergoes
cyclic changes similar to the endometrium, leading to recurrent inflammation,
fibrosis, and the formation of adhesions and cysts.
Clinically, endometriosis presents with a spectrum of symptoms including
chronic pelvic pain, dysmenorrhea, dyspareunia, irregular menstruation, and
ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
90
infertility. The impact on quality of life is profound—psychologically, socially,
and economically—making it one of the most disabling gynecological conditions
in women of reproductive age. In addition, delayed diagnosis—often 7 to 10
years after symptom onset—remains a global issue due to the nonspecific
nature of the symptoms and limited non-invasive diagnostic tools.
The pathogenesis of endometriosis is multifactorial and not yet fully
understood. Key mechanisms include retrograde menstruation, coelomic
metaplasia, immune dysfunction, angiogenesis, and oxidative stress. A critical
component contributing to disease progression is chronic systemic and local
inflammation. Elevated levels of inflammatory cytokines, reactive oxygen
species (ROS), and lipid peroxidation products have been demonstrated in
patients with endometriosis. These contribute to tissue damage, pain
sensitization, and poor reproductive outcomes.
Standard treatment options include hormonal therapy—such as
gonadotropin-releasing hormone (GnRH) agonists, oral contraceptives, and
progestins—as well as surgical excision of lesions. However, both modalities
have limitations. Hormonal therapies often produce undesirable side effects like
mood changes, libido reduction, and decreased bone mineral density, and are
contraindicated in patients seeking conception. Surgical treatment is invasive
and carries a high recurrence rate, with symptoms returning in up to 50% of
cases within five years. Consequently, there is growing demand for safer, long-
term, and patient-centered conservative treatment approaches.
Phytotherapy, or herbal-based medicine, has gained increasing attention in
the field of gynecology as an adjunct or alternative to standard care. Herbal
compounds are rich in bioactive molecules with anti-inflammatory, antioxidant,
antispasmodic, and immunomodulatory properties, which may be beneficial in
managing endometriosis without the adverse effects of synthetic drugs.
Moreover, vaginal administration allows for localized therapeutic effects with
minimal systemic exposure.
In this context, the current study proposes the use of a novel six-component
vaginal phytocomplex suppository composed of Withania somnifera
(Ashwagandha), Nigella sativa (Black seed), Propolis, Artemisia absinthium
(Wormwood), Cuminum cyminum (Zira), and Melissa officinalis (Lemon balm).
These components are selected based on their synergistic potential to reduce
inflammation, neutralize oxidative stress, modulate immune response, and
alleviate pelvic pain. Each of them has been previously studied for their
ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
91
pharmacological properties individually, but their combination in a suppository
form for the treatment of endometriosis has not been explored in clinical trials.
Thus, this study aims to evaluate the clinical and laboratory efficacy of this
innovative phytotherapeutic formulation in ambulatory patients with
endometriosis. By monitoring inflammatory markers such as C-reactive protein
(CRP), erythrocyte sedimentation rate (ESR), neutrophil-to-lymphocyte ratio
(NLR) and clinical symptoms using the Visual Analog Scale (VAS) for pelvic pain,
the goal is to establish a safe, effective, and accessible conservative therapy that
could complement or replace standard hormonal regimens in selected patient
groups.
Research Objective
To evaluate the clinical and biochemical efficacy of a six-component vaginal
phytocomplex suppository in the conservative treatment of endometriosis.
Materials and Methods
The proposed suppository formulation includes:
- Withania somnifera (Ashwagandha)
- Nigella sativa (Black seed)
- Propolis
- Artemisia absinthium (Wormwood)
- Cuminum cyminum (Zira)
- Melissa officinalis (Lemon balm)
The suppository will be administered vaginally once daily for 14 days.
Participants will include 20 outpatient women diagnosed with endometriosis
based on clinical and ultrasound findings. Evaluation criteria will include pre-
and post-treatment levels of CRP, ESR, and NLR, as well as VAS pain scores.
Expected Results and Discussion
Preliminary phytochemical screening of the six herbs used in the
formulation reveals the presence of flavonoids, alkaloids, tannins, and essential
oils—all known to modulate inflammatory and oxidative stress pathways.
Ashwagandha (Withania somnifera) is recognized for its adaptogenic and
immunomodulatory effects, which may help stabilize hormonal fluctuations.
Nigella sativa contains thymoquinone, a potent antioxidant that has shown
promise in reducing inflammatory cytokines in reproductive tissue. Propolis is
widely studied for its wound healing and anti-infective properties, while
Artemisia and Melissa offer antispasmodic and sedative benefits. Cuminum
cyminum contributes mild analgesic and anti-inflammatory support. The
ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
92
combinatory effect of these herbs in a localized vaginal route ensures targeted
action with minimal systemic absorption.
Conclusion
The development and application of a six-component vaginal phytocomplex
suppository presents a promising adjunct to conventional therapies for
endometriosis. Its integration into clinical practice could significantly improve
patient outcomes by targeting inflammation, reducing pain, and offering an
alternative for those seeking non-hormonal approaches. This strategy may
especially benefit patients with contraindications to hormonal treatments.
Future studies should aim for larger randomized controlled trials to validate its
efficacy and establish standardized dosing.
References:
1.
Al-Bayati FA. Synergistic antibacterial activity between Thymoquinone
and Lactoferrin against methicillin-resistant Staphylococcus aureus and other
pathogens. Res J Med Sci. 2008;2(5):237–241.
2.
Eslamian G, et al. The effect of Withania somnifera on hormonal imbalance
in polycystic ovary syndrome: A clinical trial. J Ayurveda Integr Med.
2020;11(4):469–474.
3.
Abdulghani M. Propolis as a natural remedy: A review. Saudi J Biol Sci.
2017;24(6):1172–1178.
4.
Jang S et al. Effects of Artemisia on menstrual pain: A review. J
Ethnopharmacol. 2021;273:113961.
5.
. Rehman S et al. Melissa officinalis: A review of phytochemistry and
therapeutic potentials. J Herb Med. 2022;31:100492.
